Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FMT for Recurrent MDRO Infections
NCT02312986Phase 1Completed
- Sponsor
- Washington University School of Medicine
- Start
- Aug 2015
- Primary completion
- Jul 2020
- Modality
- Live Biotherapeutic Products
01
Overview
Phase 1, open-label, single-arm trial of allogeneic fecal microbiota in organism colonization, sponsored by Washington University School of Medicine. Primary endpoint: Incidence and Severity of Solicited and Serious Adverse Events at 12 months. Started Aug 2015; status: completed.
02
Drugs
allogeneic fecal microbiota
03
Conditions
organism colonization
Beyond the preview
Go deeper on NCT02312986.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02312986.